Evidence map›Paper›PMID 30742088›Full record

ArticleCell death and differentiation2019

HSPA12A is required for adipocyte differentiation and diet-induced obesity through a positive feedback regulation with PPARγ.

Xiaojin Zhang, Xuan Chen, Tao Qi, Qiuyue Kong, Hao Cheng, Xiaofei Cao, Yuehua Li, Chuanfu Li, Li Liu, Zhengnian Ding

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A CCL2Nature communications · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. GRP78 Activity Moderation as a Therapeutic Treatment against Obesity.International journal of environmental research and public health · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Xiaojin ZhangDepartment of Geriatrics, Jiangsu Provincial Key Laboratory of Geriatrics,Key Laboratory of Targeted Intervention of Cardiovascular Disease, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China.
Xuan ChenDepartment of Anesthesiology, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China.
Tao QiDepartment of Anesthesiology, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China.
Qiuyue KongDepartment of Anesthesiology, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China.
Hao ChengDepartment of Anesthesiology, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China.
Xiaofei CaoDepartment of Anesthesiology, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China.
Yuehua LiKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, 210029, Nanjing, China.
Chuanfu LiDepartment of Surgery, East Tennessee State University, Johnson City, TN, 37614, USA.
Li LiuDepartment of Geriatrics, Jiangsu Provincial Key Laboratory of Geriatrics,Key Laboratory of Targeted Intervention of Cardiovascular Disease, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China. liuli@njmu.edu.cn.
Zhengnian DingDepartment of Anesthesiology, The First Affiliated Hospital with Nanjing Medical University, 210029, Nanjing, China. zhengnianding@njmu.edu.cn.
Nanjing Medical University · CNEast Tennessee State University · US

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81571290National Natural Science Foundation of China (National Science Foundation of China) 81571378National Natural Science Foundation of China (National Science Foundation of China) 81770854National Natural Science Foundation of China (National Science Foundation of China) 81870234
6 · The paper itself

Abstract

Obesity is one of the most serious public health problems. Peroxisome proliferator-activated receptor γ (PPARγ) plays the master role in adipocyte differentiation for obesity development. However, optimum anti-obesity drug has yet been developed, mandating more investigation to identify novel regulator in obesity pathogenesis. Heat shock protein 12A (HSPA12A) encodes a novel member of the HSP70 family. Here, we report that obese patients showed increased adipose HSPA12A expression, which was positively correlated with increase of body mass index. Intriguingly, knockout of HSPA12A (Hspa12a

Indexed as

3T3-L1 CellsAdipocytesAdipogenesisAdipose Tissue, WhiteAdiposityAnilidesAnimalsBody Mass IndexCell LineDiet, High-FatDNA-Binding ProteinsHSP70 Heat-Shock ProteinsHumansHyperglycemiaHyperlipidemiasMice2-chloro-5-nitrobenzanilideAnilidesDNA-Binding ProteinsHSP70 Heat-Shock ProteinsHspa12a protein, mousePPAR gammaPparg protein, mouse

Identifiers

PMID30742088
PMCPMC6888823
OpenAlexW2913784076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.